Enlarged prostate drug trial halted early
NCT ID NCT00651807
First seen Apr 11, 2026 · Last updated May 14, 2026 · Updated 4 times
Summary
This study tested a hormone drug called Org 3236 (etonogestrel) in men with an enlarged prostate causing urinary problems. The goal was to see if the drug could shrink the prostate and improve symptoms like weak urine flow and frequent urination. Only 16 men took part before the study was stopped early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BENIGN PROSTATIC HYPERPLASIA (BPH) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Instituto Médico Especializado
Buenos Aires, Hidalgo, 1405, Argentina
Conditions
Explore the condition pages connected to this study.